Stocks Overview

LAST PRICE
6.5200
TODAY'S CHANGE (%)
Trending Up0.1100 (1.7161%)

Bid / Lots
6.4500/ 3
Ask / Lots
6.5800/ 1
Open / Previous Close
6.4000 / 6.4100
Day Range
Low 6.3600
High 6.5500
52 Week Range
Low 4.0300
High 7.9500
Volume
1,404,452
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 6.41
Time	Volume	BCRX
09:32 ET	18225	6.39
09:34 ET	1000	6.42
09:36 ET	2580	6.43
09:38 ET	3239	6.39
09:39 ET	2150	6.4
09:41 ET	1600	6.41
09:43 ET	2129	6.43
09:45 ET	2005	6.46
09:48 ET	18338	6.45
09:50 ET	2642	6.46
09:52 ET	509	6.445
09:54 ET	3950	6.44
09:56 ET	3067	6.43
09:57 ET	1631	6.435
09:59 ET	400	6.43
10:01 ET	7029	6.435
10:03 ET	27032	6.49
10:06 ET	14709	6.505
10:08 ET	26726	6.51
10:10 ET	35274	6.525
10:12 ET	6708	6.535
10:14 ET	919	6.5245
10:15 ET	2113	6.46
10:17 ET	2434	6.435
10:19 ET	336	6.43
10:21 ET	2971	6.445
10:24 ET	321	6.435
10:26 ET	3272	6.4239
10:28 ET	1159	6.425
10:30 ET	4098	6.43
10:32 ET	1907	6.404
10:33 ET	1215	6.415
10:35 ET	3500	6.42
10:37 ET	964	6.42
10:39 ET	312	6.425
10:42 ET	1200	6.44
10:44 ET	3440	6.45
10:46 ET	100	6.455
10:48 ET	1572	6.45
10:50 ET	1955	6.46
10:51 ET	376	6.46
10:53 ET	239	6.4512
10:55 ET	1400	6.4501
10:57 ET	201	6.455
11:00 ET	2563	6.45
11:02 ET	577	6.42
11:04 ET	1276	6.435
11:06 ET	100	6.435
11:08 ET	370	6.4388
11:09 ET	1672	6.45
11:11 ET	1531	6.44
11:13 ET	3308	6.44
11:15 ET	2165	6.445
11:18 ET	605	6.445
11:22 ET	5455	6.43
11:24 ET	1903	6.425
11:26 ET	8713	6.44
11:27 ET	2279	6.44
11:29 ET	100	6.44
11:31 ET	2480	6.44
11:33 ET	709	6.44
11:36 ET	468	6.445
11:38 ET	298	6.44
11:40 ET	200	6.4495
11:42 ET	260	6.445
11:44 ET	3669	6.45
11:45 ET	1100	6.475
11:47 ET	8604	6.485
11:49 ET	1708	6.49
11:51 ET	1982	6.48
11:54 ET	3158	6.47
11:56 ET	2453	6.49
11:58 ET	2366	6.465
12:00 ET	921	6.46
12:02 ET	1832	6.44
12:03 ET	428	6.44
12:05 ET	300	6.44
12:07 ET	556	6.44
12:09 ET	1557	6.43
12:12 ET	1529	6.425
12:14 ET	969	6.425
12:16 ET	1118	6.425
12:18 ET	3276	6.425
12:20 ET	918	6.415
12:21 ET	1780	6.41
12:23 ET	300	6.415
12:25 ET	4037	6.425
12:27 ET	610	6.42
12:30 ET	249	6.42
12:32 ET	17239	6.385
12:34 ET	28148	6.385
12:36 ET	1293	6.38
12:38 ET	3437	6.39
12:39 ET	1128	6.38
12:41 ET	6329	6.395
12:43 ET	2400	6.3937
12:45 ET	2174	6.385
12:48 ET	1040	6.385
12:50 ET	900	6.39
12:52 ET	3200	6.39
12:54 ET	2661	6.39
12:56 ET	24420	6.415
12:57 ET	9197	6.41
12:59 ET	518	6.41
01:01 ET	200	6.4
01:03 ET	8418	6.405
01:06 ET	6672	6.4199
01:08 ET	2263	6.42
01:10 ET	300	6.42
01:12 ET	1420	6.42
01:14 ET	500	6.43
01:15 ET	1582	6.43
01:17 ET	13357	6.43
01:19 ET	4447	6.41
01:21 ET	1107	6.41
01:24 ET	500	6.42
01:26 ET	300	6.41
01:28 ET	7265	6.43
01:30 ET	783	6.44
01:32 ET	900	6.435
01:33 ET	600	6.435
01:35 ET	500	6.435
01:37 ET	701	6.435
01:39 ET	400	6.43
01:42 ET	751	6.435
01:44 ET	7537	6.45
01:46 ET	12276	6.43
01:48 ET	400	6.42
01:50 ET	400	6.42
01:51 ET	2710	6.43
01:53 ET	667	6.4288
01:55 ET	11200	6.43
01:57 ET	333	6.435
02:00 ET	602	6.434
02:02 ET	2207	6.43
02:04 ET	600	6.42
02:06 ET	2166	6.415
02:08 ET	652	6.415
02:09 ET	7566	6.405
02:11 ET	1152	6.41
02:13 ET	6981	6.41
02:15 ET	200	6.4
02:18 ET	1871	6.395
02:20 ET	2400	6.4
02:22 ET	1692	6.395
02:24 ET	800	6.4
02:26 ET	300	6.39
02:27 ET	300	6.39
02:29 ET	918	6.39
02:31 ET	6695	6.395
02:33 ET	2292	6.4
02:36 ET	2625	6.39
02:38 ET	8616	6.38
02:40 ET	1500	6.38
02:42 ET	900	6.38
02:44 ET	600	6.38
02:45 ET	4891	6.39
02:47 ET	2609	6.39
02:49 ET	2300	6.39
02:51 ET	2152	6.385
02:54 ET	1660	6.38
02:56 ET	492	6.38
02:58 ET	893	6.385
03:00 ET	4017	6.395
03:02 ET	5062	6.395
03:03 ET	19540	6.42
03:05 ET	600	6.425
03:07 ET	4661	6.45
03:09 ET	4857	6.47
03:12 ET	3009	6.47
03:14 ET	569	6.47
03:16 ET	1200	6.46
03:18 ET	4490	6.47
03:20 ET	1268	6.465
03:21 ET	1943	6.465
03:23 ET	991	6.46
03:25 ET	5581	6.465
03:27 ET	1370	6.465
03:30 ET	1489	6.465
03:32 ET	3627	6.46
03:34 ET	7909	6.48
03:36 ET	2608	6.485
03:38 ET	2595	6.485
03:39 ET	20864	6.495
03:41 ET	8130	6.495
03:43 ET	2055	6.495
03:45 ET	8972	6.51
03:48 ET	3258	6.505
03:50 ET	15023	6.5
03:52 ET	14563	6.52
03:54 ET	9060	6.52
03:56 ET	32222	6.53
03:57 ET	42194	6.52
03:59 ET	95034	6.52

Data delayed at least 15 minutes.

Jul 2, 2024
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
  7:00AM ET on Tuesday Jul 02, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesBCRX BioCryst Pharmaceuticals Inc	1.3B	-6.1x	---
United StatesMDXG MiMedx Group Inc	1.0B	18.0x	---
United StatesKNSA Kiniksa Pharmaceuticals Ltd	1.4B	227.2x	---
United StatesGLPG Galapagos NV	1.7B	49.7x	---
United StatesVCYT Veracyte Inc	1.6B	-23.0x	---
United StatesMRVI Maravai LifeSciences Holdings Inc	1.8B	-7.0x	---
As of 2024-07-07

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older.

Contact Information

Headquarters: 4505 Emperor Blvd Ste 200DURHAM, NC, United States 27703-8457
Phone: 919-859-1302
Fax: 919-859-1314

Executives

Independent Chairman of the Board: Nancy Hutson
President, Chief Executive Officer, Director: Jon Stonehouse
Chief Financial Officer: Anthony Doyle
Chief Commercial Officer: Charles Gayer
Chief Research & Development Officer: Helen Thackray

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$1.3B
Revenue (TTM)	$355.4M
Shares Outstanding	206.4M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.88
EPS	$-1.07
Book Value	$-2.21
P/E Ratio	-6.1x
Price/Sales (TTM)	3.8
Price/Cash Flow (TTM)	---
Operating Margin	-33.43%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

BioCryst Pharmaceuticals Inc
NASDAQ:BCRXUnited States

Search Criteria

Charts

Recent News

Jul 2, 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Tuesday Jul 02, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar